Abstract
All analysis of the efficiency of therapy for prostate cancer must control for the natural history of the disease. Over the past years, several long‐term series involving several hundred patients have helped to describe the results of untreated disease. In general, most patients will not die of their disease, although approximately half of the patients will develop disease progression within 10 years. Predictors of progression include tumor stage, grade, and ploidy status. © 1992 Wiley‐Liss, Inc.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 20-25 |
| Number of pages | 6 |
| Journal | Journal of Cellular Biochemistry |
| Volume | 50 |
| Issue number | S16H |
| DOIs | |
| State | Published - 1992 |
Keywords
- expectant management
- natural history
- prostate cancer
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Cell Biology
Fingerprint Dive into the research topics of 'The natural history of adenocarcinoma of the prostate'. Together they form a unique fingerprint.
Cite this
Thompson, L. M., & Chodak, G. W. (1992). The natural history of adenocarcinoma of the prostate. Journal of Cellular Biochemistry, 50(S16H), 20-25. https://doi.org/10.1002/jcb.240501206